So far, China NMPA has approved a total of 66 reagents for detection of influenza A viruses, including 23 antigen detection products, 5 antibody detection products, and 38 nucleic acid detection products. Of the 66 products, 27 were single-use products and 39 were multi-use products, with most of the multi-use products detecting both influenza A and B viruses (see the attached table for details). Moving forward, China NMPA will persist in its diligent efforts to review and approve reagents for detection of influenza A viruses, catering to the pressing demands of the current infectious disease prevention and control landscape.